RxDoctor Payments Data

Marie Ohaver

Family · Lake Havasu City, AZNPI 1396370607

Payments from drug & device makers

$1,667in general payments, 2019–2025

Across 31 payments — averaging $53.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biohaven Pharmaceuticals, Inc.$965
  • Boston Scientific$572
  • Biohaven Pharmaceutical Holding Company Ltd.$45
  • Amgen$32
  • Abbott$25
  • Lilly USA, LLC$15
  • plus $13 from 1 others

What the payments were for

  • Consulting fees$80048%
  • Food & beverage$86752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,667 in reported general payments places this provider in the 75th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Medicare billing

Part B allowed, 2024
$25,891
Medicare patients
57
Services billed
413

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$33,207
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$814
Levothyroxine Sodium81$700
Albuterol Sulfate HfaAlbuterol Sulfate29$691
Trazodone Hcl39$581
Omeprazole45$572
Rosuvastatin Calcium50$483
Losartan Potassium66$471
Atorvastatin Calcium81$398
Potassium Chloride15$391
Gabapentin14$383
Duloxetine Hcl13$380
Pantoprazole Sodium26$322
Escitalopram Oxalate28$291
Cyclobenzaprine Hcl11$271

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$33,20717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,119 family providers in Arizona.

Other family in Lake Havasu City

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →